Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Adsorbed Tetanus Vaccine in Adults
NCT06120751Phase 3Completed
- Sponsor
- CanSino Biologics Inc.
- Start
- Mar 2024
- Primary completion
- Apr 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Tetanus Vaccine (Adsorbed) in Tetanus, sponsored by CanSino Biologics Inc.. Started Mar 2024; status: completed.
02
Drugs
Tetanus Vaccine (Adsorbed)
03
Conditions
Tetanus
Beyond the preview
Go deeper on NCT06120751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06120751.